Skip to main content
FinSpry Logo
FinSpry
A
AIM
(NYSEAMERICAN)
AIM ImmunoTech Inc.
$0.41-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AIM ImmunoTech (AIM) Stock Price & Financial Analysis

AIM ImmunoTech Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.27 - $0.69
52-Week High$19.74
52-Week Low$0.27
Open$0.28
Volume467.98M
Average Volume (3M)16.35M
Market Cap409.51K
Shares Outstanding1.62M
Price to Sales (P/S)4.65
Price to Book (P/B)-0.04
EV/EBITDA-0.15
Revenue (TTM)88.00K
Net Income (TTM)-13.96M
Free Cash Flow (TTM)-11.45M
EPS (TTM)$-8.66
Profit Margin-15861.36%
Operating Margin-13254.55%
50-Day MA$0.61
200-Day MA$1.57
52-Week Change-96.83%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About AIM ImmunoTech

What is the current stock price for AIM?

As of the latest trading session, AIM stock trades at $0.41. The 52-week range is $0.27–$19.74, with a day range of $0.27–$0.69.

What is the P/E ratio for AIM?

The P/E ratio (Price-to-Earnings) for AIM is shown in the Key Statistics section. This valuation metric helps compare AIM ImmunoTech Inc. to industry peers.

Does AIM pay dividends?

AIM ImmunoTech does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AIM?

Based on 1 analyst, the consensus for AIM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AIM?

AIM ImmunoTech's market capitalization is $660,396.96, classifying it as a micro-cap company. AIM ImmunoTech operates in the Healthcare sector within the Biotechnology industry.